Literature DB >> 27766542

The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal.

James Demetrios Douketis1,2.   

Abstract

The American College of Chest Physicians recently updated their practice guidelines for the treatment of patients with venous thromboembolism, comprising deep vein thrombosis and pulmonary embolism. The 2016 guidelines represent the tenth iteration of these guidelines, which are widely used, and are considered as the reference standard for practice guidelines related to venous thromboembolism. The objectives of this review are to highlight the key recommendations that are new in these guidelines, to address recommendations that may be considered controversial, and to touch on areas of ongoing research that may better inform some of these recommendations.

Entities:  

Keywords:  Anticoagulants; Practice guideline; Treatment; Venous thromboembolism

Mesh:

Substances:

Year:  2016        PMID: 27766542     DOI: 10.1007/s11739-016-1553-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  28 in total

1.  Edoxaban versus warfarin for venous thromboembolism.

Authors:  Harry R Büller
Journal:  N Engl J Med       Date:  2014-01-02       Impact factor: 91.245

2.  Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial).

Authors:  Mohsen Sharifi; Curt Bay; Laura Skrocki; Farnoosh Rahimi; Mahshid Mehdipour
Journal:  Am J Cardiol       Date:  2012-10-24       Impact factor: 2.778

3.  Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel.

Authors:  Suresh Vedantham; Susan R Kahn; Samuel Z Goldhaber; Anthony J Comerota; Sameer Parpia; Sreelatha Meleth; Diane Earp; Rick Williams; Akhilesh K Sista; William Marston; Suman Rathbun; Elizabeth A Magnuson; Mahmood K Razavi; Michael R Jaff; Clive Kearon
Journal:  Vasc Med       Date:  2016-05-30       Impact factor: 3.239

4.  Aspirin for preventing the recurrence of venous thromboembolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Alessandro Schenone; Sabine Eichinger; Eugenio Bucherini; Mauro Silingardi; Marina Bianchi; Marco Moia; Walter Ageno; Maria Rita Vandelli; Elvira Grandone; Paolo Prandoni
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

5.  Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH.

Authors:  C Kearon; W Ageno; S C Cannegieter; B Cosmi; G-J Geersing; P A Kyrle
Journal:  J Thromb Haemost       Date:  2016-06-07       Impact factor: 5.824

6.  Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial.

Authors:  Susan R Kahn; Stan Shapiro; Philip S Wells; Marc A Rodger; Michael J Kovacs; David R Anderson; Vicky Tagalakis; Adrielle H Houweling; Thierry Ducruet; Christina Holcroft; Mira Johri; Susan Solymoss; Marie-José Miron; Erik Yeo; Reginald Smith; Sam Schulman; Jeannine Kassis; Clive Kearon; Isabelle Chagnon; Turnly Wong; Christine Demers; Rajendar Hanmiah; Scott Kaatz; Rita Selby; Suman Rathbun; Sylvie Desmarais; Lucie Opatrny; Thomas L Ortel; Jeffrey S Ginsberg
Journal:  Lancet       Date:  2013-12-06       Impact factor: 79.321

7.  Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).

Authors:  A Tosetto; A Iorio; M Marcucci; T Baglin; M Cushman; S Eichinger; G Palareti; D Poli; R C Tait; J Douketis
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

8.  Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Susan R Kahn; Jim Julian; Elizabeth Magnuson; Michael R Jaff; Timothy P Murphy; David J Cohen; Anthony J Comerota; Heather L Gornik; Mahmood K Razavi; Lawrence Lewis; Clive Kearon
Journal:  Am Heart J       Date:  2013-03-05       Impact factor: 4.749

9.  D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study.

Authors:  Gualtiero Palareti; Benilde Cosmi; Cristina Legnani; Emilia Antonucci; Valeria De Micheli; Angelo Ghirarduzzi; Daniela Poli; Sophie Testa; Alberto Tosetto; Vittorio Pengo; Paolo Prandoni
Journal:  Blood       Date:  2014-05-30       Impact factor: 22.113

Review 10.  Guidance for the management of venous thrombosis in unusual sites.

Authors:  Walter Ageno; Jan Beyer-Westendorf; David A Garcia; Alejandro Lazo-Langner; Robert D McBane; Maurizio Paciaroni
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

View more
  6 in total

1.  Semi-empirical anticoagulation model (SAM): INR monitoring during Warfarin therapy.

Authors:  Marco Bontempi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-15       Impact factor: 2.745

2.  Predictive factors of venous recanalization in upper-extremity vein thrombosis.

Authors:  Gaëtan Ploton; Nicolas Brebion; Béatrice Guyomarch; Marc-Antoine Pistorius; Jérôme Connault; Jeanne Hersant; Alizée Raimbeau; Guillaume Bergère; Mathieu Artifoni; Cécile Durant; Giovanni Gautier; Romain Dumont; Jean-Manuel Kubina; Claire Toquet; Olivier Espitia
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

Review 3.  Management dilemmas in acute ischemic stroke and concomitant acute pulmonary embolism: Case series and literature review.

Authors:  Faddi G Saleh Velez; Jorge G Ortiz Garcia
Journal:  eNeurologicalSci       Date:  2021-04-15

4.  Outcome and treatments of dogs with aortic thrombosis: 100 cases (1997-2014).

Authors:  Mackenzie Ruehl; Alex M Lynch; Therese E O'Toole; Bari Morris; John Rush; C Guillermo Couto; Samantha Hmelo; Stacey Sonnenshein; Amy Butler; Julien Guillaumin
Journal:  J Vet Intern Med       Date:  2020-08-15       Impact factor: 3.333

5.  Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies.

Authors:  Carlos Tortosa; Oscar Cabrera-Marante; Manuel Serrano; José A Martínez-Flores; Dolores Pérez; David Lora; Luis Morillas; Estela Paz-Artal; José M Morales; Daniel Pleguezuelo; Antonio Serrano
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

Review 6.  A Comprehensive Literature Review on the Management of Distal Deep Vein Thrombosis.

Authors:  Sohaip Kabashneh; Vijendra Singh; Samer Alkassis
Journal:  Cureus       Date:  2020-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.